Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Open accessThe DOI matches its Crossref record; 621 of the 628 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have marked insulin resistance, independent of obesity. This article summarizes the state of the science since we last reviewed the field in the Endocrine Reviews in 1997. There is general agreement that obese women with PCOS are insulin resistant, but some groups of lean affected women may have normal insulin sensitivity. There is a post-binding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation that selectively affects metabolic but not mitogenic pathways in classic insulin target tissues and in the ovary. Constitutive activation of serine kinases in the MAPK-ERK pathway may contribute to resistance to insulin's metabolic actions in skeletal muscle. Insulin functions as a co-gonadotropin through its cognate receptor to modulate ovarian steroidogenesis. Genetic disruption of insulin signaling in the brain has indicated that this pathway is important for ovulation and body weight regulation. These insights have been directly translated into a novel therapy for PCOS with insulin-sensitizing drugs. Furthermore, androgens contribute to insulin resistance in PCOS. PCOS may also have developmental origins due to androgen exposure at critical periods or to intrauterine growth restriction. PCOS is a complex genetic disease, and first-degree relatives have reproductive and metabolic phenotypes. Several PCOS genetic susceptibility loci have been mapped and replicated. Some of the same susceptibility genes contribute to disease risk in Chinese and European PCOS populations, suggesting that PCOS is an ancient trait.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin resistance and hyperinsulinemia, either directly or indirectly, through factors such as adiposity can lead to increase circulating androgen levels (6).”
From Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (2025) · cites this paper as [6]
In the citing paper
“Androgen excess favors visceral fat deposition and lipid dysfunction with a vicious cycle of worsening of hyperinsulinemia and insulin resistance (6).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [6]
In the citing paper
“primarily due to hyperinsulinemia resulting from insulin resistance, which increases ovarian androgen production [162, 163].”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [163]
In the citing paper
“Moreover, women who have both obesity and PCOS exhibit a greater level of insulin resistance in comparison to obese persons who do not have PCOS [53].”
In the citing paper
“Consensus is yet to be achieved in lean women with PCOS as IR is not consistently demonstrated (Diamanti-Kandarakis and Dunaif, 2012).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Diamanti-Kandarakis and Dunaif, 2012
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Research works printed but not linked: 5
- Achard, 1921, Le virilisme et son association à l'insuffisance glycolytique (diabète des femmes à barbe), Bull Acad Natl Med (Paris), 86, 51
- Vague, 1947, La différentiation sexuelle. Facteur determinant des formes de l'obesité, Presse Med, 55, 339
- Chereau, 1844, Mémoires pour servir à l'étude des malades ovaires
- Givens, 1992, Historical Overview of the Polycystic Ovary, 3
- Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome; towards a rational approach, 377
Cited by
Items 101–200 of 1,006
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
“However, when comparable diagnostic criteria were applied, the prevalence rates were still different in various studies [17], suggesting that environmental factors, such as lifestyle, contribute to the presence of obesity in PCOS [32, 33].”
BackgroundTrikudanathan, S. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.003 · Cited by 159
Renaming PCOS—A Two-State Solution
Dunaif, A., & Fauser, B. C. J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2040 · Cited by 134
Self-citationEnhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome
Adams, J., Liu, Z., Ren, Y. A., Wun, W.-S., Zhou, W., Kenigsberg, S., Librach, C., Valdes, C., Gibbons, W., & Richards, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4275 · Cited by 134
“Hyperinsulinemia appears to impact ovulatory dysfunction by multiple mechanisms, including promoting a generalized inflammatory state characterized by increased systemic levels of C-reactive protein (CRP), central adiposity, and altered adipokine production, all of which may play a role in the PCOS phenotype and be li…”
BackgroundAlmenning, I., Rieber-Mohn, A., Lundgren, K. M., Shetelig Løvvik, T., Garnæs, K. K., & Moholdt, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138793 · Cited by 155
“This is in line what the common finding of postprandial dysglycemia reported in women with PCOS, reflecting peripheral, primarily skeletal muscle, IR rather than fasting dysglycemia (for a review, see [11]).”
BackgroundGestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154
Premature adrenarche: Etiology, clinical findings, and consequences
Voutilainen, R., & Jääskeläinen, J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.06.004 · Cited by 154
The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review
Krul-Poel, Y. H. M., Snackey, C., Louwers, Y., Lips, P., Lambalk, C. B., Laven, J. S. E., & Simsek, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0617 · Cited by 126
Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome
Gao, Y., Zou, Y., Wu, G., & Zheng, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1193749 · Cited by 157
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148
“It is a result of protein modifications, such as increased IRS-1 serine phosphorylation, which affects metabolic pathways in many tissues, including the ovary [48].”
BackgroundAdiponectin protects against development of metabolic disturbances in a PCOS mouse model
Benrick, A., Chanclón, B., Micallef, P., Wu, Y., Hadi, L., Shelton, J. M., Stener-Victorin, E., & Wernstedt Asterholm, I. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708854114 · Cited by 137
“High levels of circulating androgens and insulin resistance are hallmarks of PCOS and increase the risk of women with PCOS developing type 2 diabetes (25).”
BackgroundOXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome
Rudnicka, E., Duszewska, A. M., Kucharski, M., Tyczyński, P., & Smolarczyk, R. (2022) · Reproduction · doi:10.1530/rep-22-0152 · Cited by 150
Gooren, L. J., Wierckx, K., & Giltay, E. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0011 · Cited by 136
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 145
The effect of cinnamon on polycystic ovary syndrome in a mouse model
Dou, L., Zheng, Y., Li, L., Gui, X., Chen, Y., Yu, M., & Guo, Y. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0418-y · Cited by 141
Niu, Z., Lin, N., Gu, R., Sun, Y., & Feng, Y. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3942 · Cited by 129
Chen, J., Lin, P., Tsai, Y.-R., Yang, Y.-C., & Kang, H. (2019) · Cells · doi:10.3390/cells8111318 · Cited by 141
An update of genetic basis of PCOS pathogenesis
Crespo, R. P., Bachega, T. A. S. S., Mendonça, B. B., & Gomes, L. G. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000049 · Cited by 138
“Defects in metabolic actions of insulin occur in muscle and adipose tissues, but mitogenic and steroidogenic actions of insulin in ovaries are preserved (28).”
BackgroundHeimark, D., McAllister, J., & Larner, J. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0423 · Cited by 126
Fernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137
“Thus, when women with PCOS have high body weight, they are affected by both intrinsic and extrinsic insulin resistance.(3) PCOS has recently been conceptualized as a condition of severe metabolic stress,(25) a position that we support as it provides a way to account for the pervasive molecular and biochemical derangem…”
BackgroundInfluentialEpigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
Kokosar, M., Benrick, A., Perfilyev, A., Fornes, R., Nilsson, E., Maliqueo, M., Behre, C. J., Sazonova, A., Ohlsson, C., Ling, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22883 · Cited by 137
Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
Krul-Poel, Y. H. M., Koenders, P. P., Steegers‐Theunissen, R. P. M., ten Boekel, E., ter Wee, M. M., Louwers, Y. V., Lips, P. T. A. M., Laven, J. S. E., & Şimşek, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204748 · Cited by 136
Cao, J., Huo, P., Cui, K., Wei, H., Cao, J., Wang, J., Liu, Q., Lei, X., & Zhang, S. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00876-6 · Cited by 134
“Women with PCOS suffer from widespread depression and anxiety, and PCOS can exert long-term harmful effects on women’s physical and mental health [5].”
BackgroundKazemi, M., Hadi, A., Pierson, R. A., Lujan, M. E., Zello, G. A., & Chilibeck, P. D. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa092 · Cited by 102
“Changes in insulin concentrations in response to interventions are faster in women with PCOS when compared with glucose concentrations (7, 41, 42), which could explain significant reductions in both HOMA-IR and fasting insulin in response to LGI diets in the current work.”
BackgroundŁagowska, K., Bajerska, J., & Jamka, M. (2018) · Nutrients · doi:10.3390/nu10111637 · Cited by 112
Lonardo, M. S., Cacciapuoti, N., Guida, B., Lorenzo, M. D., Chiurazzi, M., Damiano, S., & Menale, C. (2024) · Current Obesity Reports · doi:10.1007/s13679-023-00531-2 · Cited by 135
“IR has been described to be intrinsic to PCOS, independently of adiposity [43].”
BackgroundHyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
“In addition, as might be expected from pronounced metabolic dysfunction accompanying most PCOS phenotypes, mothers and fathers of women with PCOS have increased prevalence of T2D, metabolic syndrome and dyslipidemia [34,36].”
BackgroundOntogeny of the ovary in polycystic ovary syndrome
Dumesic, D. A., & Richards, J. S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.011 · Cited by 120
Implications and Future Perspectives of AGEs in PCOS Pathophysiology
Merhi, Z. O., Kandaraki, E., & Diamanti‐Kandarakis, E. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.01.005 · Cited by 130
Self-citationThe Influence of Metabolic Factors and Diet on Fertility
Łakoma, K., Kukharuk, O., & Śliż, D. (2023) · Nutrients · doi:10.3390/nu15051180 · Cited by 136
Behboudi-Gandevani, S., Ramezani Tehrani, F., Rostami Dovom, M., Farahmand, M., Bahri Khomami, M., Noroozzadeh, M., Kabir, A., & Azizi, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1117069 · Cited by 109
“In addition, Obesity is one of the common feature of the PCOS [55].”
BackgroundPolycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
Livadas, S., Anagnostis, P. G., Bosdou, J. Κ., Bantouna, D., & Paparodis, R. D. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i1.5 · Cited by 131
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022) · Women s Health · doi:10.1177/17455057221117966 · Cited by 131
Guan, Y., Wang, D., Bu, H., Zhao, T., & Wang, H. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5150684 · Cited by 106
“Obese women with PCOS show lower ISOGTT and higher LH to stimulate androgen secretion, triggering insulin resistance and excessive androgens [42].”
BackgroundIzadi, A., Ebrahimi, S., Shirzai, S., Taghizadeh, S., Parizad, M., Farzadi, L., & Pourghassem Gargari, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01221 · Cited by 95
High-Fat Diet Induces Significant Metabolic Disorders in a Mouse Model of Polycystic Ovary Syndrome1
Lai, H., Jia, X., Yu, Q., Zhang, C., Qiao, J., Guan, Y., & Kang, J. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.120063 · Cited by 112
Ovulation induction in polycystic ovary syndrome
Tanbo, T. G., Mellembakken, J. R., Bjercke, S., Ring, E., Åbyholm, T., & Fedorcsák, P. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13395 · Cited by 125
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y.-H., Bertrand, F., Gower, B., & Azziz, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad356 · Cited by 123
Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis
Escobar-Morreale, H. F., & Roldán-Martín, M. B. (2016) · Diabetes Care · doi:10.2337/dc15-2577 · Cited by 123
“In general, thepresence of androgen excess associates with a more severe cardiometabolic phenotype in patients with PCOS (3).”
BackgroundInfluentialZhao, Y., Tao, M., Wei, M., Du, S., Wang, H., & Wang, X. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1669619 · Cited by 122
“Moreover, PCOS is related to metabolic abnormalities including hyperinsulinemia, insulin resistance, obesity and hyperandrogenism [3,4].”
BackgroundLi, Z., Gao, Z., Sun, T., Zhang, S., Yang, S., Zheng, M., & Shen, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1098570 · Cited by 93
“Polycystic ovarian syndrome (PCOS) is a women’s endocrine condition with more susceptibility to insulin resistance and T2DM, of which one common treatment is insulin sensitizers (88).”
BackgroundAdipokines in reproductive function: a link between obesity and polycystic ovary syndrome
Chen, X., Jia, X., Qiao, J., Guan, Y., & Kang, J. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0247 · Cited by 107
Jones, M. R., Brower, M. A., Xu, N., Cui, J., Mengesha, E., Chen, Y.-D. I., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005455 · Cited by 111
“The role of insulin in PCOS has been widely studied [26].”
BackgroundJózkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 121
Kazemi, M., McBreairty, L. E., Chizen, D. R., Pierson, R. A., Chilibeck, P. D., & Zello, G. A. (2018) · Nutrients · doi:10.3390/nu10101387 · Cited by 118
“Women with PCOS exhibit profound metabolic abnormalities including peripheral insulin resistance (IR) and compensatory hyperinsulinemia, impaired glucose metabolism, dyslipidemia, hypertension, and abdominal adiposity [3,4].”
BackgroundJensterle, M., Kravos, N. A., Pfeifer, M., Kocjan, T., & Janez, A. (2015) · Hormones · doi:10.1007/bf03401383 · Cited by 117
Teede, H. J., Misso, M. L., Boyle, J. A., Garad, R. M., McAllister, V., Downes, L., Gibson‐Helm, M., Hart, R. J., Rombauts, L., Moran, L., et al. (2018) · Medical Journal of Australia · doi:10.5694/mja18.00656 · Cited by 115
Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome
Nehir, A., Baştu, E., Demiral, İ., Bulut, H., Doğan, M., & Buyru, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2016.1155208 · Cited by 114
“Other studies in the literature have also presented increased levels of TNF-a in PCOS [21,22].”
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
Iervolino, M., Lepore, E., Forte, G., Laganà, A. S., Buzzaccarini, G., & Unfer, V. (2021) · Nutrients · doi:10.3390/nu13051677 · Cited by 98
“This metabolic alteration is an indicator for increased cardiovascular risk and for the development of other serious related diseases, including type 2 diabetes, hypertension, and metabolic syndrome [39].”
BackgroundConway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0252 · Cited by 113
Self-citationYang, Y., Zhou, W., Wu, S., Tang, W., Wang, Z., Zhou, Z., Li, Z.-W., Huang, Q.-F., He, Y., & Zhou, H. (2021) · Endocrinology · doi:10.1210/endocr/bqab118 · Cited by 113
“Although increased ovarian and/or adrenal androgen secretion (7, 8), partial folliculogenesis arrest (8, 9), insulin resistance (10-12), neuroendocrine axis dysfunction (8), and genetic factors (13) have been suggested to be involved in the development of PCOS, the precise underlying triggers for these key biochemical…”
BackgroundPathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome
Gorsic, L. K., Kosova, G., Werstein, B., Sisk, R., Legro, R. S., Hayes, M. G., Teixeira, J. M., Dunaif, A., & Urbanek, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00612 · Cited by 104
Self-citationPolycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 113
Chen, M., He, C., Zhu, K., Chen, Z., Meng, Z., Jiang, X., Cai, J., Yang, C., & Zuo, Z. (2021) · Theranostics · doi:10.7150/thno.67167 · Cited by 111
“PCOS is associated with many complications, such as obesity [48, 49], insulin resistance [50, 51], and hyperandrogenism [52].”
BackgroundSteroids and insulin resistance in pregnancy
Vejražková, D., Včelák, J., Vaňková, M., Lukášová, P., Bradnová, O., Hálková, T., Kancheva, R. L., & Bendlová, B. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.11.007 · Cited by 111
“to induce androgen production [30,43] and, consequently, hyperandrogenemia directly promotes peripheral insulin resistance in women [29,30,43,115].”
BackgroundReappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 110
“This can present as impairments in the metabolic and/or mitotic branches of insulin signaling in various tissues, including canonical insulin targets (Diamanti-Kandarakis & Dunaif 2012) and nonclassical targets such as ovaries (Rice et al. 2005, Guo et al. 2022).”
Kidger, A. M., Rushworth, L. K., Stellzig, J., Davidson, J., Bryant, C., Bayley, C., Caddye, E., Rogers, T., Keyse, S. M., & Caunt, C. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614684114 · Cited by 110
“Proc Natl Acad Sci USA 111(51):18267–18272.”
Recent advances in understanding and managing cholesterol gallstones
Ciaula, A. D., & Portincasa, P. (2018) · F1000Research · doi:10.12688/f1000research.15505.1 · Cited by 105
Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
Rizk, M. G., & Thackray, V. G. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa177 · Cited by 104
“However, it also suggests that obesity and IR are prerequisites for PCOS, although it is well documented that not all women diagnosed with PCOS are obese or insulin resistant [52, 53].”
BackgroundLi, S., Chu, Q., Ma, J., Sun, Y., Tao, T., Huang, R., Liao, Y., Yue, J., Zheng, J., Wang, L., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2692 · Cited by 89
“Obesity is associated with abnormal adipokine secretion, elevated serum free fatty acids (FFAs), and metabolic disorders associated with abnormal steroid hormone function in adipose tissue, resulting in low-grade chronic inflammation, insulin resistance, and abnormal glucose tolerance ([4,6]).”
BackgroundInfluentialIncreased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
Subramanian, A., Anand, A., Adderley, N. J., Okoth, K., Toulis, K. A., Gokhale, K. M., Sainsbury, C. A. R., O’Reilly, M., Arlt, W., & Nirantharakumar, K. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1163 · Cited by 104
“Women with PCOS are at significantly increased risk of type 2 diabetes mellitus (T2DM) (12, 13, 14), non-alcoholic fatty liver disease (NAFLD) (15) and cardiovascular disease (16).”
Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models
Laws, M. J., Neff, A. M., Brehm, E., Warner, G. R., & Flaws, J. A. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.008 · Cited by 103
Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome
Hu, L., Ma, L., Xia, X., Ying, T., Zhou, M., Zou, S., Yu, H., & Yin, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac294 · Cited by 104
Western-style diet, sex steroids and metabolism
Varlamov, O. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.025 · Cited by 103
“PCOS is a common neuroendocrine disorder in women, which results in ovarian dysfunction, infertility and metabolic syndrome [121], including visceral obesity and insulin resistance [122-124].”
BackgroundSexual Function, Obesity, and Weight Loss in Men and Women
Rowland, D. L., McNabney, S. M., & Mann, A. R. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.03.006 · Cited by 91
Serum AMH levels and insulin resistance in women with PCOS
Şahmay, S., Mathyk, B. A., Sofiyeva, N., Atakul, N., Azemi, A., & Erel, C. T. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.03.007 · Cited by 101
HMGB1‐induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS
Zhang, C., Hu, J., Wang, W., Sun, Y., & Sun, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000605rr · Cited by 93
AbuelEzz, N. Z., Shabana, M. E.-A., Abdel-Mageed, H. M., Rashed, L. A., & Morcos, G. N. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118003 · Cited by 100
Yu, O., Christ, J. P., Schulze‐Rath, R., Covey, J., Kelley, A., Grafton, J. R., Cronkite, D., Holden, E., Hilpert, J., Sacher, F., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.04.010 · Cited by 101
Baldani, D. P., Škrgatić, L., & Ougouag, R. (2015) · International Journal of Endocrinology · doi:10.1155/2015/786362 · Cited by 101
“Even before the Rotterdam criteria were adopted, it was evident that different subgroups of PCOS existed and it was even suggested that these subgroups differed metabolically [6].”
BackgroundMethodInfluentialGonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish
Yan, Y., Desvignes, T., Bremiller, R., WILSON, C. A., Dillon, D. M., High, S. K., Draper, B. W., Buck, C. L., & Postlethwait, J. H. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24579 · Cited by 100
“PCOS patients are also insulin resistant with low levels of insulin receptor (Diamanti-Kandarakis and Dunaif, 2012; van Houten and Visser, 2014; Dehghan et al., 2016).”
BackgroundPrevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome
Livadas, S., Pappas, C., Karachalios, A., Marinakis, E., Tolia, N., Drakou, M., Kaldrymides, P., Panidis, D., & Diamanti‐Kandarakis, E. (2014) · Endocrine · doi:10.1007/s12020-014-0200-7 · Cited by 99
Self-citationLiu, M., Gao, J., Zhang, Y., Li, P., Wang, H., Ren, X., & Li, C. (2015) · Clinical Endocrinology · doi:10.1111/cen.12951 · Cited by 100
Gower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98
“PCOS is one of the most common endocrine disorders in premenopausal women (44).”
BackgroundHyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
Amato, M. C., Vesco, R., Vigneri, E., Ciresi, A., & Giordano, C. S. D. S. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0372-x · Cited by 274
“1 3 other hand, the distinct molecular mechanisms of insulin in PCOS result in substantial hyperinsulinism causing hyperandrogenemia and anovulation [3, 4].”
BackgroundGorsic, L. K., Dapas, M., Legro, R. S., Hayes, M. G., & Urbanek, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02178 · Cited by 87
Elkind-Hirsch, K. E., Chappell, N., Seidemann, E., Storment, J., & Bellanger, D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab408 · Cited by 96
Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study
Daan, N. M. P., Koster, M. P. H., de Wilde, M. A., Dalmeijer, G. W., Evelein, A. M. V., Fauser, B. C. J. M., & de Jager, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165033 · Cited by 96
Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome
LENTSCHER, J. A., & DeCherney, A. H. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000563 · Cited by 96
The importance of estradiol for body weight regulation in women
Vigil, P., Meléndez, J., Petkovic, G., & Río, J. P. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.951186 · Cited by 98
Dong, F., Deng, D., Chen, H., Cheng, W., Li, Q., Luo, R., & Ding, S. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8670-x · Cited by 97
“Compared with non-IR PCOS women, IR PCOS patients are more susceptible to develop infertility, T2DM, and cardiovascular diseases [11].”
BackgroundPapadakis, G. E., Kandaraki, E., Tseniklidi, E., Papalou, O., & Diamanti‐Kandarakis, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00388 · Cited by 95
Self-citationDobbie, L. J., Pittam, B., Zhao, S. S., Alam, U., Hydes, T., Barber, T. M., & Cuthbertson, D. J. (2023) · Human Reproduction · doi:10.1093/humrep/dead053 · Cited by 95
Chen, L., Xu, W., & Zhang, D. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.06.027 · Cited by 96
Fraison, E., Kostova, E., Moran, L. J., Bilal, S., Ee, C. C., Venetis, C., & Costello, M. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005552.pub3 · Cited by 94
Dapas, M., Sisk, R., Legro, R. S., Urbanek, M., Dunaif, A., & Hayes, M. G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02496 · Cited by 92
Self-citationNilsson, E., Benrick, A., Kokosar, M., Krook, A., Lindgren, E., Källman, T., Martis, M. M., Højlund, K., Ling, C., & Stener-Victorin, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00935 · Cited by 93
Polycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role?
Sobolewski, M., & Barrett, E. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371088 · Cited by 75
“It is estimated that 60–80 percent of women with PCOS also have insulin resistance [74].”
BackgroundSathyapalan, T., David, R. M., Gooderham, N. J., & Atkin, S. L. (2015) · Scientific Reports · doi:10.1038/srep16890 · Cited by 94
Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
Dumesic, D. A., Phan, J. D., Leung, K. L., Grogan, T. R., Ding, X., Li, X., Hoyos, L. R., Abbott, D. H., & Chazenbalk, G. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02086 · Cited by 92
Long term complications of polycystic ovary syndrome (PCOS)
Peigné, M., & Dewailly, D. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.07.111 · Cited by 92
Brabaharan, S., Veettil, S. K., Kaiser, J. E., Rao, V. R. R., Wattanayingcharoenchai, R., Maharajan, M. K., Insin, P., Talungchit, P., Anothaisintawee, T., Thakkinstian, A., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.43730 · Cited by 92
Long-term consequences of obesity on female fertility and the health of the offspring
Chandrasekaran, S., & Neal-Perry, G. S. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000364 · Cited by 92
Abdalla, M. A., Deshmukh, H., Atkin, S. L., & Sathyapalan, T. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118174 · Cited by 92
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Chang, C. L., Huang, S. Y., Hsu, Y. C., Chin, T. H., & Soong, Y. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42061-9 · Cited by 92
Zhu, Y., Li, Y., Liu, M., Hu, X., & Zhu, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00575 · Cited by 91
“Insulin resistance affecting about 44–70% of PCOS patients (12), is believed to be a key factor in the development of PCOS, closely related to chronic inflammation (1, 13, 14).”
BackgroundLiu, D., Gao, X., Pan, X., Zhou, T., Zhu, C., Li, F., Fan, J., Targher, G., & Zhao, J. (2023) · BMC Medicine · doi:10.1186/s12916-023-02775-0 · Cited by 93
“In the ovarian theca cells, insulin may exert a co-gonadotropin effect on upregulating luteinizing hormone (LH)-induced androgen production [48].”
BackgroundMetabolic hormones are integral regulators of female reproductive health and function
Athar, F., Karmani, M., & Templeman, N. M. (2024) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 94
“However, PCOS has heterogeneous symptoms that often include obesity, elevated insulin, and/or a diminished capacity for glucose disposal [89,90].”
BackgroundJamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2015) · Reproductive Health · doi:10.1186/1742-4755-12-7 · Cited by 80
“However, the presence of two PCOS phenotypes identified according to the Rotterdam criteria—hyperandrogenism and polycystic ovaries with ovulatory cycles and anovulation and polycystic ovaries without hyperandrogenism—show little or no evidence of IR using surrogate markers [7].”
BackgroundMethod
Metadata
- Authors
- Diamanti-Kandarakis, E., & Dunaif, A.
- Affiliations
- Medical School, University of Athens (E.D.-K.), Athens GR-14578, Greece
- Northwestern University (US)
- ORCID
- Dunaif, Andrea
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-10-12
- Volume
- 33
- Issue
- 6
- Pages
- 981-1030
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC5393155
- OpenAlex
- W1967263394
- Semantic Scholar
- b2b7fa060bf61f261edf17bef51cbbbd222742e0
- Cited by
- 1,947
- References
- 628
- Citations by year
- 2026: 183 · 2025: 178 · 2024: 182 · 2023: 221 · 2022: 191 · 2021: 184 · 2020: 136 · 2019: 140 · 2018: 108 · 2017: 97 · 2016: 96 · 2015: 92 · 2014: 91 · 2013: 43 · 2012: 4
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073411)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405, R01HD057223, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, insulin resistance, insulin receptor signaling, MAPK/ERK pathway, skeletal muscle insulin sensitivity, ovarian steroidogenesis, ovulation, brain insulin signaling, body weight regulation, insulin-sensitizing drugs, androgens, developmental origins of health and disease, fetal growth restriction, genetic susceptibility loci, type 2 diabetes risk, lean PCOS
- MeSH terms
- Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Reproduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.